HC Wainwright Forecasts Lineage Cell Therapeutics Q1 Earnings
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 earnings estimates for Lineage Cell Therapeutics in a research report issued on Tuesday, March 11th. HC Wainwright analyst J. Pantginis expects that the company will earn ($0.01) per share for the quarter. HC Wainwright has a “Buy” […]
